Giovanni Parmigiani
@g_parmigiani
Followers
505
Following
80
Media
3
Statuses
116
Statistics. Genomics. Inherited Cancer Susceptibility. Prediction. PhD @CMU_Stats Prof @dfcidatascience @HarvardBiostats https://t.co/HlQeV9wDWR
Joined May 2021
Our validation of carrier probability models for Lynch syndrome done jointly by groups who proposed alternative models. Peace. https://t.co/XHr9KpzyQL
#LynchSyndrome #GeneChat
0
1
6
We’re very proud that President Biden has chosen Dr. Monica Bertagnolli to lead the NCI. She is an eminent surgeon with extensive clinical and leadership experience. Monica will be a superb leader at the NCI at a time when cancer research is so promising.
4
13
87
Our colleague Timothy Rebbeck, PhD, spoke with @yahoolife about the importance of cancer prevention and early detection to help save more lives.
0
3
8
Data Science Postdoc Open House 2022 — see you there!
0
1
3
📈 A different approach to #science inviting humility, broader measures of excellence and success, #diversity in our networks, and the creation of pathways to #inclusive education via @PNASNews: https://t.co/fGqT6dCFfz
#datascience #ethics
pnas.org
Science has traditionally been driven by curiosity and followed one goal: the pursuit of truth and the advancement of knowledge. Recently, ethics, ...
2
3
5
.@DanaFarber is proud to join nearly 90 organizations calling on Congress to pass legislation to improve diversity in clinical trials. Removing barriers and enhancing diversity in clinical trials is a moral and scientific imperative. Congress must act.
0
8
42
Amazing @racecancer Series. Racing as it should be: small, friendly, in a great spot and for the benefit of cancer research. See you tomorrow?
0
0
1
The statistical backbone of our PanelPRO familial cancer risk model is out https://t.co/r2tBaEqUtz Congrats to lead Jane Liang (who just defended and is heading out to Stanford), Danielle Braun, and awesome collaborators at City of Hope. @DrStephenGruber
onlinelibrary.wiley.com
Risk evaluation to identify individuals who are at greater risk of cancer as a result of heritable pathogenic variants is a valuable component of individualized clinical management. Using principles...
1
0
4
The call for “ISBA New Researcher Travel Award" for #BaYSM2022 is now open! Send your CV to us at baysm.isba@gmail.com on or before June 6, 2022 to be considered for the travel award.
1
8
13
Remarkable group here! Congrats to the newest members of the COPSS Leadership Academy 🏅 This is a terrific initiative recognizing and engaging the rising stars of our profession
Congratulations to our 2022 Leadership Academy! Xi Chen @nataliexdean
@DavinaDurgana Philip Ernst @PierreEJacob
@KLdivergence
@LesterMackey
@BetsyOgburn
https://t.co/STg7OkoaGt
0
2
4
An important and substantive development from @FDAOncology Making clinical trials more representative by including all types of people on clinical trials is longtime goal of @theNCI and this new guidance is great news.
2
17
63
0
1
0
Check out this new program, UNC EDGE: 'Educational Pathways to Increase Diversity in GEnomics', a 2-year summer program for undergraduate students who are interested in careers in genomics. See tweet below for application details https://t.co/JZlljN5wo1
0
14
22
"All variables have been dichotomised for the analysis" (sigh) Never ceases to amaze me why go to the effort/expense to collect data, then discard some of it by dichotomising Illustration of harm of commonly applied methods in prediction https://t.co/EidykU8dUm
#statstwitter
1
9
37
The Master in Data Science and Statistical Learning #MD2SL of @UNI_FIRENZE in collaboration with @IMTLucca is about to begin! #SaveTheDate for the Kick-Off Meeting: online tomorrow at 4:30 pm with our students, teachers and partner institutions. https://t.co/iljlmTSHA8
0
6
7